[HTML] nature.com

[HTML][HTML] Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab

Z Na, SP Yeo, SR Bharath, MW Bowler, E Balıkçı… - Cell research, 2017 - nature.com
PD-1 is a type I immune inhibitory transmembrane receptor of the CD28 family that
modulates the activity of T cells in peripheral tissues [1]. It is expressed in T cells, B cells …
被引用次数：145 相关文章

[引用][C] Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab

Z Na, SP Yeo, SR Bharath, MW Bowler, E Balıkçı… - Cell Research, 2016 - cir.nii.ac.jp
Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody
pembrolizumab | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab.

Z Na, SP Yeo, SR Bharath, MW Bowler, E Balıkçı… - Cell …, 2016 - europepmc.org
PD-1 is a type I immune inhibitory transmembrane receptor of the CD28 family that
modulates the activity of T cells in peripheral tissues 1. It is expressed in T cells, B cells …

[引用][C] Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab

Z Na, SP Yeo, SR Bharath, MW Bowler… - Cell …, 2017 - pubmed.ncbi.nlm.nih.gov
Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody
pembrolizumab Structural basis for blocking PD-1-mediated immune suppression by …
[HTML] nih.gov

[HTML][HTML] Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab

Z Na, SP Yeo, SR Bharath, MW Bowler, E Balıkçı… - Cell …, 2017 - ncbi.nlm.nih.gov
PD-1 is a type I immune inhibitory transmembrane receptor of the CD28 family that
modulates the activity of T cells in peripheral tissues [1]. It is expressed in T cells, B cells …

Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab.

Z Na, SP Yeo, SR Bharath, MW Bowler, E Balıkçı… - Cell …, 2016 - europepmc.org
PD-1 is a type I immune inhibitory transmembrane receptor of the CD28 family that
modulates the activity of T cells in peripheral tissues [1]. It is expressed in T cells, B cells …